Recently , our company received a patent certificate from National Intellectual Property Administration ( Certificate No1824832), The name of invention patent is D-Dimer Coagulation Control Plasma and Its Prepare Method, and the patent No is ZL 201310090638.4.
D-Dimer is one kind of special degradation products of cross-linked fibrin .The elevated D-Dimer level could reflect the double activation of coagulation and fibrinolysis system, can be one of molecular markers of hypercoagulatibility and hyperfibrinolysis,has great clinical meaning to diagnostic deep venous thrombosis, myocardial infarction and so on. This invention mainly adopt way of in vitro simulation, solved deficient exisiting in domestic technology. It has many advantages such as convenient operation, high sensitivity and low cost.